ET Digital UP Conclave: ‘Technology empowering governance, driving industrial growth in UP'
Governance is empowered through digital technology, and the digital push in turn fuels industrial growth, experts said during a panel discussion on 'Digital Uttar Pradesh: Engine for Industrial Growth' during the ET Digital UP Conclave on Friday.
Mission director, National Health Mission, UP, and secretary, medical, health and family welfare department, Pinky Jowel said, "Many new things have been introduced in the health sector in last two years. For example, E Kavach is a comprehensive digital health application that has data on all health schemes. It incorporates a registry of every individual in the state."
"Every ASHA worker has smartphone and laptop.
Similar is the case with ANMs and community health officers. They capture all data related to health systems into E Kavach, which helps us analyse and form policies for future. So, this is a digital revolution that even our lowest field workers can record all immunisation, screening of diabetes and hypertension, and we are adding more health issues to it," she said.
"ABHA ID is another innovation incorporated along with E Kavach.
It is a kind of smart card with a QR code, and it has the digitised health ID of an individual," she added.
"The govt is working on technology-enabled governance, and to ensure this, we must take care of the basic needs of technology user. It should be error-free, transparent, and simple to use. The biggest example of technology-enabled governance is the booking of railway tickets. Earlier, it was tough to get a ticket in offline mode, but now, within seconds, a ticket is booked," said CEO, Uttar Pradesh State Industrial Development Authority (UPSIDA), Mayur Maheshwari.
"The power of technology is such that with meaningful interventions, we can make daily lives of common people easy. UPSIDA's digital platform was earlier used by around 800 users, but now around 11,000 people are using it monthly," he added.
"In UP, 98% of industries are MSMEs, and the number is huge. This sector has less automation and a huge number of employees. In industrial areas, all land approval, bank loans, and incentive disbursement are online," said secretary, MSME and Export Promotion and Infrastructure & Industrial Development Department, Pranjal Yadav.
He said the govt's focus was to make interactions online to make things easy for artisans and craftsmen.
"We have come up with an Alexa kind of device, with sticky films that capture pathogens. It hovers over farms and detects pathogens, which is otherwise a challenging task in agriculture sector," said national sales head, ABM Knowledgeware Ltd, Lokesh Sharma.
The session was moderated by managing director, Foundation for Innovation and Technology Transfer (FITT), Indian Institute of Technology, Delhi, Nikhil Agarwal.
Get the latest lifestyle updates on Times of India, along with
Brother's Day wishes
,
messages
and quotes !
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
26 minutes ago
- Indian Express
UP govt's ‘fully state-funded pharma park' invites centres from Gujarat pharma industry
A delegation from the Uttar Pradesh government, visiting Ahmedabad on Friday to promote its upcoming Bulk Drug Pharma Park in UP's Lalitpur district, announced that five companies, including Bharat Biotech and Dr Reddy's Laboratories, have already been allocated land and begun to set up their units. In total, 26 companies have expressed interest, including NATCO Pharma, Vins Bioproducts Ltd, and Rockwell Industries Ltd. The outreach event was held in collaboration with the Confederation of Indian Industry (CII). Mayur Maheshwari, CEO of the Uttar Pradesh State Industrial Development Authority (UPSIDA) and an IAS officer, addressed industry stakeholders and highlighted the park's strategic importance in reducing India's dependence on China for bulk drug production. Appealing directly to the Gujarat pharma industry, he said, 'We've come to Ahmedabad, which has shown the way for India. We request you to set up a parallel centre (in UP). We are more than ready to welcome you with open arms and we hope to match and provide even better facilities…' 'We have had this vacuum of bulk drugs and formulation in India. About 60% of Active Pharmaceutical Ingredients (APIs) are imported from China. This dependence is not only strategic, but it is a challenge to our entrepreneurs. If China can do it, why not UP and the rest of India?' Maheshwari said. During an interaction with the press, Maheshwari said that Gujarat was an important link for the Bulk Drug Pharma Park for its connectivity to the ports. Invoking cultural and spiritual references, Maheshwari said, 'This is the land of Shri Ram, Shri Krishna and Shri Buddha. When these three powers are present in a state, in a country, there can only be prosperity.' He praised the Yogi Adityanath-led government's leadership, citing the 'successful' hosting of the Mahakumbh, where 67 crore people had the opportunity to take the holy dip and that it 'went very well'. 'This is the first completely state-funded pharma park. All the money is from the UP government. We don't need to approach the Centre. Himachal Pradesh got a bulk drug pharma park in 2020-21 which is a non starter. In Andhra Pradesh, it has been four years and it is still just starting out… For allocation of resources and funding, we will do this on our own, which has not been possible even in Andhra and Gujarat,' said Maheshwari. When asked about skilled manpower by a stakeholder, Maheshwari said, 'We have developed a Promote Pharma initiative, which is a Section 8 company to strengthen and develop capacity building. It will invite the best professionals and will have industry, academia and govt linkage. Need-based professionals will come from there. We are also trying to get a National Institute of Pharmaceutical Education and Research (NIPER) in UP, to add to this ecosystem.' The Bulk Drug Pharma Park is coming up in Lalitpur district, located near the geographic centre of India. Delegation members highlighted that Uttar Pradesh has 14 airports, six of them international, and a dedicated helipad is also planned within the park. Additionally, both the Eastern and Western dedicated Railway Freight Corridors pass through the state, further strengthening connectivity. In the first phase, the UP government is developing 352 acres of the park. Officials said that 1,500 acre were already available for future expansion and that the park can be scaled up to 5,000 acres if needed. Maheshwari said, 'Lalitpur was also chosen because it is important to avail environmental clearance (EC) for the bulk drug and API industries. This place has less habitation. We have already got the EC. Masterplan is also approved and facility building work is already underway.' Of the park's total area, 67% is reserved for industry, 13% for green spaces, and the rest for support infrastructure and common facilities. Comparing it to other pharma parks in other states, Maheshwari said, 'We have lab testing, R&D incubation facilities, common climate controlled warehouses and technical regulatory support. We have these facilities which are missing in other places like Genome Park in Telangana and Jawaharlal Nehru Pharma City in Vizag of Andhra Pradesh.' On land pricing, he explained, 'We are giving land on a 90 year lease at Rs 75-77 lakh per acre but those setting up anchor units on 35-50 acre land will get 10% more discount. Basically, it is at Rs 1,700 per square metre of land for anchor units and Rs 1,914 per square metre for normal units. There is a 2% additional waiver if you make a full one-time payment.' Maheshwari said the park's incentives fall under the UP Pharma and Medical Devices Policy 2023 and include capital and interest subsidies, stamp duty exemption, patent and clinical trial support, a 10-year electricity duty waiver, and subsidies for quality certifications. Asked when companies can start operations, Maheshwari said, 'Right now.'
Time of India
5 hours ago
- Time of India
Hey Siri, Am I Okay? : AI tools are being trained to detect suicidal signals.
Live Events Suicidal risk identification on SNS: The prompts fed to AI do not remain confined to tasks related to needing help in everyday activities, such as asking Alexa to play the family's favourite song, asking Siri on a random Tuesday to set a reminder, or asking Google Assistant to search the song based on humming. But what if users, in an especially low moment, were to ask, 'Am I okay?' Or maybe other such prompts that insinuate the user's want to harm themselves, whether through means of self-harm or and suicide attempts remain alarmingly prevalent, requiring more effective strategies to identify and support individuals at high risk. Current methods of suicide risk assessment largely rely on direct questioning, which can be limited by subjectivity and inconsistent interpretation. Simply put, their accuracy and predictive value remain limited, regardless of the large variety of scales that can be used to assess the risk; predictability remains unimproved over the past 50 intelligence and machine learning offer new ways to improve risk detection, but their accuracy depends heavily on access to large datasets that can help identify patient profiles and key risk factors. As outlined in a clinical review, AI tools can help identify patterns in the dataset, generate risk algorithms, and determine the effect of risk and protective factors on suicide. The use of AI reassures healthcare professionals with an improved accuracy rate, especially when combined with their skills and expertise, even when diagnostic accuracy could never reach 100%.According to Burke et al. , there are three main goals of machine learning studies in suicide: the first is improving the accuracy of risk prediction, the second is identifying important predictors and the interaction between them, and the last one is to model subgroups of patients. At an individual level, AI could allow for better identification of individuals in crisis and appropriate intervention, while at a population level, the algorithm could find groups at risk and individuals at risk of suicide attempts within these groups. Social media platforms have become both the cause and solution for the mental health crisis. While they are often criticized for contributing to the mental health crisis, these platforms also provide a rich source of real-time data to AI, enabling it to identify individuals portraying signs of suicidal intent. This is achieved by analyzing users' posts, comments, and behavioral patterns, allowing AI tools to detect linguistic cues, such as expressions of hopelessness or other emotional signals that may indicate psychological distress. For instance, Meta employs AI algorithms to scan user content and identify signs of distress, allowing the company to reach out and offer support or even connect users with crisis helplines. Studies such as those by the Black Dog Institute also demonstrate how AI's natural language processing can flag at-risk individuals earlier than traditional methods, enabling timely are also companies such as Samurai Labs and Sentinet that have developed AI-driven systems that monitor social media content and flag posts that insinuate suicidal ideation. For example, Samurai Labs 'One Life' project scans online conversations to detect signs that indicate high suicide risk. Upon detecting these indicators, the platform then leads the user to support resources or emergency assistance. In the same manner, Sentient's algorithms analyze thousands of posts on a daily basis, triggering alerts when users express some form of emotional distress, allowing for timely AI isn't a replacement for human empathy or professional mental health care, it offers a promising advancement in suicide prevention. By identifying warning signs at a much faster and more precise rate than human diagnosis and enabling early interventions, AI tools can serve as valuable allies in this fight against suicide.
Time of India
20 hours ago
- Time of India
UP to hold roadshow in Ahmedabad to boost pharma sector investment
Lucknow: The Yogi government, in collaboration with the UP State Industries Development Authority and Confederation of Indian Industry, is set to host a roadshow in Ahmedabad on Friday to showcase opportunities in the pharmaceutical sector. An official spokesperson stated that the pharma sector is a key catalyst towards achieving the one trillion-dollar economy goal. Senior officials, including Mayur Maheshwari, CEO of UPSIDA, and Awanish Kumar Awasthi, advisor to the CM, are likely to address the business community in the Gujarat capital. The state govt is actively promoting the sector through initiatives like the creation of mega drug parks and the establishment of dedicated institutions for pharma research and innovation. These efforts are built on the existing base, which includes the presence of the Central Drug Research Institute lab and a large number of pharmaceutical units, particularly in the formulation sector, located in districts like Ghaziabad, Lucknow, and Kanpur. Additionally, the state has a robust network of pharma educational institutes. "The govt is actively fostering innovation and entrepreneurship in the pharmaceutical sector through the establishment of incubation centres and 'Promote Pharma', a dedicated institution for pharma research and innovation," said a govt officer. An assessment by Invest UP shows that the pharmaceutical sector attracted nearly Rs 2,845 crore in investment and generated over 70,000 jobs in three years. "Over the past three years, the state attracted investments worth approximately Rs 2,845 crore in the pharmaceutical sector via the single window portal. This includes investments in manufacturing units, blood centres, and drug retail establishments," the officer stated. Between 2022–23 and 2024–25, around 167 manufacturing units were set up, creating about 3,340 jobs. In the same period, 195 blood centres and 32,475 medicine retail outlets were also established, creating approximately 1,365 and 64,995 jobs, respectively. The Pharmaceutical and Medical Device Policy, 2023 has further strengthened investor confidence. The policy offers several incentives, including a stamp duty exemption of Rs 3.89 crore, encouraging new investments and the expansion of existing businesses. This has led to a spike in both manufacturing facilities and retail operations within the state. The list of investment opportunities also includes the development of the Lalitpur Bulk Drug Park, which is progressing significantly.
